Claims for Patent: 5,965,788

Summary for Patent: 5,965,788

Title:	Transgenic non-human mammal comprising a rabbit WAP promoter
Abstract:	A transgenic non-human mammal is provided where the genome of the mammal comprises a DNA construct comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein. Methods of using the mammal in the production of recoverable amounts of a heterologous protein in the mammal\'s milk are discussed and described such that the mammal is a bio-reactor for a heterologous protein of interest. Furthermore, cells isolated from the mammal are provided for the production of a heterologous protein of interest in vitro, as well as, DNA constructs of the rabbit WAP promoter for the production of the transgenic non-human mammal.
Inventor(s):	Houdebine; Louis-Marie (Buc, FR), Devinoy; Eve (Gif-Sur-Yvette, FR), Thepot; Dominique (Livry-Gargan, FR)
Assignee:	Institut National de la Recherche Agronomique (Paris, FR)
Application Number:	08/162,146
Patent Claims:	1. A transgenic non-human mammal whose genome comprises a DNA construct comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter has a length of at least 3.0 kilobases extending upstream from the transcription initiation site defined as nucleotide 1822 of the DNA sequence of the rabbit WAP gene depicted in SEQ. ID. NO: 2, and wherein said mammal expresses said DNA sequence such that a recoverable amount of said heterologous protein is produced in the milk of said mammal. 2. A process for the preparation of a heterologous protein in the milk of a female, non-human transgenic mammal comprising: (a) providing a female, non-human transgenic mammal whose genome comprises a DNA construct comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter has a length of at least 3.0 kilobases extending upstream from the transcription initiation site defined as nucleotide 1822 of the DNA sequence of the rabbit WAP gene depicted in SEQ. ID. NO: 2; (b) recovering milk from said female, non-human transgenic mammal; and (c) extracting said heterologous protein from said milk. 3. The process as claimed in claim 2, wherein said rabbit WAP promoter has a length between 3.0 to 6.3 kilobases extending upstream from said transcription initiation site. 4. The process as claimed in claim 2, wherein said rabbit WAP promoter has a length of 6.3 kilobases extending upstream from said transcription initiation site. 5. The process as claimed in claim 2, wherein said rabbit WAP promoter has a length of 17.6 kilobases extending upstream from said transcription initiation site. 6. The process as claimed in claim 2, wherein the initiator ATG of said DNA sequence has been deleted. 7. The process as claimed in claim 2, wherein the recovering step (b) and extracting step (c) comprises: (i) recovering mammary glands from said female, non-human transgenic mammal; (ii) incubating said mammary glands at a temperature of about 0.degree. C. for a period of time ranging from two hours to 18 hours; (iii) recovering the milk that has exuded from the mammary glands in step (b); and (iv) isolating the heterologous protein from the exuded milk of step (c). 8. The process of as claimed in claim 2, where said DNA sequence encodes human growth hormone. 9. The process of as claimed in claim 2, where said DNA sequence encodes a heterologous protein selected from the group consisting of growth factors, interleukins, colony stimulating factors, kinases, and blood coagulation factors. 10. The process of as claimed in claim 2, where said DNA sequence encodes a heterologous protein selected from the group consisting of erythropoietin, G-CSF, .alpha.1-antitrypsin, urokinase, hirudin and factor VIII. 11. The process of as claimed in claim 2, where said DNA sequence consists of intron I of the human factor VIII gene operably linked to the cDNA encoding human factor VIII-.DELTA.II. 12. A process for the preparation of a heterologous protein in the milk of a female, non-human transgenic mammal comprising: (i) providing said female, non-human transgenic mammal whose genome comprises a DNA sequence comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter is the 6.3 kilobase HindIII-BamHI restriction fragment depicted in FIG. 1; (ii) recovering milk from said female, non-human transgenic mammal; and (iii) extracting said heterologous protein from said milk. 13. A process for the preparation of a heterologous protein in the milk of a female, non-human transgenic mammal comprising: (i) providing said female, non-human transgenic mammal whose genome comprises a DNA sequence comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter is the HindIII-EcoRI restriction fragment depicted in FIG. 1; (ii) recovering milk from said female, non-human transgenic mammal; and (iii) extracting said heterologous protein from said milk. 14. An isolated mammalian cell comprising a genome which comprises a DNA construct comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter has a length of at least 3.0 kilobases extending upstream from the transcription initiation site defined as nucleotide 1822 of the DNA sequence of the rabbit WAP gene depicted in SEQ. ID. NO: 2. 15. The mammalian cell as claimed in claim 14, wherein said cell is a mammary epithelial cell. 16. A DNA construct comprising in operable association a rabbit WAP promoter and a DNA sequence encoding a heterologous protein, wherein said rabbit WAP promoter has a length of at least 3.0 kilobases extending upstream from the transcription initiation site defined as nucleotide 1822 of the DNA sequence of the rabbit WAP gene depicted in SEQ. ID. NO: 2.

Details for Patent 5,965,788

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	01/16/1978		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26